Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1944.8000
26.80
(
1.40
%)
NSE
Aug 11, 2025
15:31 PM
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
07 Aug 2025
1944.80
1.40%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2400 | Upside : 23.4%
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,500/share.
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
IPO action stays active with four new issues and six listings this week
|
11 Aug 2025, 06:17PM
Market closes higher, L&T wins an order worth over Rs 15,000 crore from Adani Power
Trendlyne Marketwatch |
11 Aug 2025, 03:56PM
Lupin expects normalization by September quarter
|
17 Apr 2020